A Phone-Based Program to Help Teenagers With Asthma Take Daily Inhalers
Tests a mobile health program for taking daily asthma inhalers in teenagers.
Plain-language title generated from the registry record
Registry title: Asthma Ctrl SMART Trial
Key facts
- Where
- Aurora and Cincinnati, United StatesSee the 2 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 12 and 18 years old?
Source: NCT07512622, who can take part
Where in United States
- University of Colorado AMCAurora, United StatesNo longer taking part
- Cincinnati Children's Hospital Medical CenterCincinnati, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Children's Hospital Medical Center, Cincinnati
- Trial code
- NCT07512622
- Record updated
- 4 November 2026
- Original description
The primary objective is to examine the efficacy of an mHealth adherence intervention (Asthma Ctrl) on adherence to daily inhaled corticosteroids as measured by electronically monitored adherence in adolescents with asthma. The secondary objective is to compare the effectiveness of three intervention strategies: 1. asthma management app (control); 2. Asthma Ctrl; 3. Asthma Ctrl+ on adherence, lung function, and health care utilization at post-intervention and 1- and 6-month follow-up. The third objective is to explore and contrast different challenges and combinations of challenges to identify which are most impactful in determining response to the three intervention strategies.Read full original descriptionShow less
Improving Medication Adherence Using an Adaptive mHealth Intervention in Adolescents With Asthma.
The primary objective is to examine the efficacy of an mHealth adherence intervention (Asthma Ctrl) on adherence to daily inhaled corticosteroids as measured by electronically monitored adherence in adolescents with asthma. The secondary objective is to compare the effectiveness of three intervention strategies: 1. asthma management app (control); 2. Asthma Ctrl; 3. Asthma Ctrl+ on adherence, lung function, and health care utilization at post-intervention and 1- and 6-month follow-up. The third objective is to explore and contrast different challenges and combinations of challenges to identify which are most impactful in determining response to the three intervention strategies.
Inclusion: Patient age between 12-18 years; Patient is diagnosed with severe-persistent or moderate-persistent asthma per NAEPP asthma guidelines; Patient is prescribed at least one daily inhaled controller medication or a daily combination inhaled corticosteroid and long-acting beta-agonist and a beta-agonist bronchodilator; English fluency for patient, caregiver, and clinician.
Exclusion: Patient receives school administered daily controller medication at the time of the enrollment visit; Diagnosis of serious mental illness (e.g., schizophrenia); Diagnosis of pervasive developmental disorder; Active chronic disease apart from asthma or allergic disease (e.g. Bronchiectasis, pulmonary hypertension, and moderate or severe tracheomalacia); Significant cognitive deficits that may interfere with comprehension per medical team or chart review.